Readers are undoubtedly confused by the reference to 1000 percent tariffs on prescription drugs. We don’t call our protection for prescription...
Vous n'êtes pas connecté
Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government. New York Times pharmaceutical reporter, Rebecca Robbins, explains how.
Readers are undoubtedly confused by the reference to 1000 percent tariffs on prescription drugs. We don’t call our protection for prescription...
Black voters are not monolithic. Astead W. Herndon, a national reporter for The New York Times and the host of the politics podcast “The Run-Up,”...
Resources are flowing into Springfield, Ohio, after weeks of negative attention fueled by Donald Trump’s presidential campaign and right-wing social...
Minnesota Gov. Tim Walz and Ohio U.S. Sen. J.D. Vance faced off Tuesday in their first and only vice presidential debate. But both brought up...
New York Times: Can this drug really extend health span and delay ageing?
The gap between the growth in GTA housing stock and the region's population is the widest it has been in over 50 years, according to the Building...
Last week, a group of British Columbia's most prominent developers kicked off a letter-writing campaign against the Metro Vancouver Regional District...
Fellow Nigerians, as I address you today, I am deeply aware of the struggles many of you face in these challenging times. Our administration knows...
The United States federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price...
This is one in a series of States Newsroom reports on the major policy issues in the presidential race. WASHINGTON — With the clock ticking on...